CEECAT Capital Signs Definitive Agreement to Sell Hermann Müller Medizintechnik to STERIS plc

 

CEECAT Capital has entered into a definitive agreement to sell Hermann Müller Medizintechnik GmbH (HMM), a leading specialist manufacturer of sterilization container systems and surgical devices, to STERIS Plc (NYSE: STE). The transaction is subject to customary closing conditions, including applicable regulatory approvals.

We invested in HMM in June 2021, partnering with founder Mehmet Aygün to unlock the company’s global potential. Under the leadership of CEO Benjamin Mietz, and with CEECAT Capital’s active support, HMM has grown into a Tuttlingen-headquartered medtech platform, pairing German leadership, knowledge and brand with a highly efficient manufacturing base in Turkey. Through targeted investments in commercial expansion, operations and regulatory capabilities, HMM secured FDA clearance, launched a Made-in-Germany assembly line for its surgical motor systems, and broadened its reach worldwide, more than tripling revenues while significantly strengthening profitability. Today, HMM serves customers in more than 90 countries.